<DOC>
	<DOCNO>NCT00295516</DOCNO>
	<brief_summary>In pregnancy complicate Rhesus disease , mother develop antibody cross placenta cause anemia death fetus . When anemia detect time , fetus save give blood transfusion pregnancy . The standard test predict whether fetus need blood transfusion examination amniotic fluid . To obtain fluid needle insert womb , risk preterm delivery , infection , make disease worse . This call amniocentesis . A new safe test , use Doppler ultrasound , develop possibly replace amniocentesis . The aim study compare new Doppler test standard amniocentesis . If Doppler test least good , safe test may replace amniocentesis management pregnancy Rhesus disease .</brief_summary>
	<brief_title>Doppler Amniocentesis Predict Fetal Anemia</brief_title>
	<detailed_description>In pregnancy complicate red cell alloimmunization , fetus may suffer chronic progressive hemolytic anemia . Severe fetal anemia lead hydrops fetal demise occur early 17 week ’ gestation , pregnancies manifestation disease neonatal hyperbilirubinemia . The standard care management pregnancy select patient risk fetal anemia use information obstetric history , serial maternal serum antibody measurement . The selected patient follow closely , usually referral center special interest expertise manage relatively rare disease . Ultrasound evaluation fetal condition , emphasis sign fetal hydrops , perform regularly . In addition , serial amniocentesis do assess amniotic fluid bilirubin ( deltaOD450 ) value . This spectrophotometric method estimate level bilirubin amniotic fluid , correlate severity hemolytic process . Although diagnostic test , introduce Liley 1961 , serve fetal medicine specialist well almost 40 year , invasive nature method consider serious disadvantage . Furthermore , reliability question , especially used second trimester . In past decade , noninvasive alternative method predict degree fetal anemia develop . The promising new diagnostic test Doppler measurement fetal blood flow velocity . Fetal blood flow velocity show correlate linearly degree anemia . Recently , middle cerebral artery ( MCA ) peak flow velocity measurement report reliably predict presence absence fetal anemia . The aim study compare performance new noninvasive diagnostic test standard test , amniocentesis amniotic fluid deltaOD450 value . In international multicenter setting , large cohort consecutive Rh-alloimmunized pregnancy study prospectively . Both diagnostic test perform simultaneously patient , compare “ gold standard ” , fetal blood sampling ( FBS ) assess actual hemoglobin concentration .</detailed_description>
	<criteria>Pregnant woman red cell alloimmunization associate risk fetal anemia ( D , E , c Duffy ( Fya ) antibody , alone combination antibody ) Gestational age 12 34 week study entry , viable fetus accurate date Maternal serum testresult , threshold fetus consider risk develop hemolytic anemia thus potential candidate invasive testing . Presence Kellantibodies Presence fetal hydrops first ultrasonographic examination Major fetal congenital chromosomal anomaly</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Rhesus</keyword>
	<keyword>Isoimmunization</keyword>
	<keyword>Red Cell Alloimmunization</keyword>
	<keyword>Fetal Hemolytic Anemia</keyword>
	<keyword>Erythroblastosis fetalis</keyword>
</DOC>